 Phase: Phase IIType: BiomarkerLaboratory analysis, TreatmentStatus: Temporarily closedAge: 18 and overSponsor: Pharmaceutical IndustryProtocol IDs: CLGX818A2202, 2013-005014-34, NCT02109653Phase: Phase IType: BiomarkerLaboratory analysis, TreatmentStatus: ClosedAge: 18 and overSponsor: Pharmaceutical IndustryProtocol IDs: CLGX818X2101, 2011-000556-42, NCT01436656 